EMCDDA Best practice portal update 8. November 2019, section EUDA news Neurostimulation techniques for the treatment of substance use 08.11.2019
10. March 2026 From essential medicine to illicit commodity: new EU report reveals how ketamine diversion is fuelling the illicit market in Europe Ketamine produced legitimately outside the EU to make medicines is increasingly finding its way onto Europe’s illicit drug...
